Global Contraceptives Market: Research & Forecast (2018-2023) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “Global Contraceptives Market Research and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.
Global contraceptives market is expected to grow rapidly due to increasing adoption of contraceptive drugs and devices in the emerging economies such as India and China.
Major drivers involved in the growth of the market are rising prevalence of sexually transmitted diseases globally and increasing significance of family planning in the Asia Pacific. At the same time, the substantial increase in the investments in print advertisements and digital advertisements is significantly contributing in the growth of the global contraceptives market.
The side effects associated with the contraceptive drugs and devices is the major factor hampering the market growth. Moreover, the growing geriatric population and rising prevalence of infertility among women due to sedentary lifestyle are some other factors that are restraining the growth of the global contraceptives market.
However, the increasing demand for affordable contraceptives methods, which includes Sino-Implants, and introduction of novel contraceptive methods such as SILCs diaphragms is expected to fuel the market growth in the near future.
Among the type of products, the contraceptive devices segment holds the largest market share in the global contraceptives market. This is majorly attributed to the wide adoption of male and female condoms across the globe. These contraceptive devices are easy-to-use, inexpensive, and consists of least side effects, which in turn, increases its demand among the youth across the globe.
North America contributes the largest market share in the global contraceptives market. This is mainly owing rapid development in the contraceptive methods in the region. Moreover, the supportive government regulations and initiatives taken by the regulatory bodies to increase awareness regarding the sexually transmitted diseases are some other factors that are significantly fueling the market growth.
Asia Pacific is projected to be the most opportunistic region in the global contraceptives market over the forecast period. This is due to favorable family planning policies led by the government and introduction of various reimbursement policies such as the AIDS care policy is expected to positively impact the revenue of contraceptives market in the region.
Some of the key players operating in the global contraceptives market are Allergan, Bayer AG, Church & Dwight Co., Inc., Cipla Limited, CooperSurgical Inc., Mankind Pharma, Merck & Co., Inc., Pfizer Limited, Teva Pharmaceuticals, Inc., and The Female Health Company Ltd., among others.
In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development, among others. For instance, in July, 2018, the Government of India has launched an app, Antararaj, in the states of India. The app will enable users in the tracking of the usage of contraceptive services, which in turn will minimize the chances of drop-out.
DriversIncreasing Adoption of Contraceptives in Emerging Economies Rising Prevalence of Sexually Transmitted Diseases Government Initiatives Regarding Early Prevention of Unintended Pregnancies Increasing Significance of Family Planning Substantial Increase in the Investments on Advertisement
RestraintsSide Effects of Contraceptive Drugs and Devices Growing Geriatric Population Rising Prevalence of Infertility Among Women
OpportunitiesDoorstep Delivery of Contraceptives in Rural Areas Introduction of Novel Methods Such as Silcs Diaphragms Increasing Demand for Affordable Contraceptive Devices Such as Sino-Implants
Key Topics Covered
Chapter 1. Report Summary
Chapter 2. Market Overview & Insights
Chapter 3. Market Determinant
Chapter 4. Market Segmentation
Chapter 5. Competitive Landscape
Chapter 6. Regional Analysis
Chapter 7. Company ProfilesAabha Contraceptives Pvt. Ltd. Agile Therapeutics Inc. Alkem Health Care Allergan Apothecus Pharmaceutical Corp Bayer AG Blairex Laboratories Inc. Caya Church & Dwight Co. Inc. Cipla Limited Contraline Inc. Coopersurgical Inc. Cupid Limited Egemen International Foundation Consumer Healthcare Gyneas 1 Hll Lifecare Limited Janssen-Cilag Limited Lupin Pharmaceuticals Inc. Mankind Pharma Mayer Laboratories Inc. Medicines360 Medisafe Distribution Inc. Melbea Innovations Mylan N.V. Pfizer Limited Piramal Enterprises Pregna International Limited SMB Corporation of India Syzygy Healthcare LLC Taiwan Fuji Latex Co. Ltd. Teva Pharmaceuticals Inc. Trimedic Inc. TTK Healthcare Vardhaman Lifecare Pvt Ltd. and more...
For more information about this report visit https://www.researchandmarkets.com/research/w75qg9/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005314/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/30/2018 10:45 AM/DISC: 11/30/2018 10:45 AM